Association of common polymorphisms in TNFA, NFkB1 and NFKBIA with risk and prognosis of esophageal squamous cell carcinoma

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Umar, Meenakshi ^a   Upadhyay, Rohit ^a,b   Kumar, Shaleen ^a   Ghoshal, Uday Chand ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

3' UNTRANSLATED REGION; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ETHNICITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; INDIAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

CARCINOMA, SQUAMOUS CELL; DEMOGRAPHY; ENVIRONMENT; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; I-KAPPA B PROTEINS; LINKAGE DISEQUILIBRIUM; LYMPH NODES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NF-KAPPA B P50 SUBUNIT; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84891897522     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081999     Document Type: Article

References (56)

1. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420: 860-867. doi:10.1038/nature01322. PubMed: 12490959.
2. Hussain SP, Harris CC (2007) Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 121: 2373-2380. doi:10.1002/ijc.23173. PubMed: 17893866.
3. Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436. doi:10.1038/nature04870. PubMed: 16724054.
4. Szlosarek P, Charles KA, Balkwill FR (2006) Tumour necrosis factor-alpha as a tumour promoter. Eur J Cancer 42: 745-750. doi:10.1016/j.ejca.2006.01.012. PubMed: 16517151.
5. Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487-501. doi:10.1016/S0092-8674(01)00237-9. PubMed: 11239407.
6. Chen G, Goeddel DV (2002) TNF-R1 signaling: a beautiful pathway. Science 296: 1634-1635. doi:10.1126/science.1071924. PubMed: 12040173.
7. Tselepis C, Perry I, Dawson C, Hardy R, Darnton SJ et al. (2002) Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action. Oncogene 21: 6071-6081. doi:10.1038/sj.onc.1205731. PubMed: 12203119.
8. Mestiri S, Bouaouina N, Ahmed SB, Khedhaier A, Jrad BB et al. (2001) Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. Cancer 91: 672-678. doi:10.1002/1097-0142(20010215)91:4. PubMed: 11241233.
9. Li M, You Q, Wang X (2011) Association between polymorphism of the tumor necrosis factor alpha-308 gene promoter and colon cancer in the Chinese population. Genet Test Mol Biomarkers 15: 743-747. doi:10.1089/gtmb.2011.0068. PubMed: 21631297.
10. Liu CJ, Wong YK, Chang KW, Chang HC, Liu HF et al. (2005) Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma. J Oral Pathol Med 34: 608-612. doi:10.1111/j.1600-0714. 2005.00359.x. PubMed: 16202081.
11. Singh H, Jain M, Sachan R, Mittal B (2009) Association of TNFA (-308G>A) and IL-10 (-819C>T) promoter polymorphisms with risk of cervical cancer. Int J Gynecol Cancer 19: 1190-1194. doi:10.1111/IGC.0b013e3181a3a3af. PubMed: 19823053.
12. Barbisan G, Pérez LO, Contreras A, Golijow CD (2012) TNF-alpha and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk. Tumour Biol 33: 1549-1556. doi:10.1007/s13277-012-0408-1. PubMed: 22592655.
13. Wu HC, Chang CH, Chen HY, Tsai FJ, Tsai JJ et al. (2004) p53 gene codon 72 polymorphism but not tumor necrosis factor-alpha gene is associated with prostate cancer. Urol Int 73: 41-46. doi:10.1159/000078803. PubMed: 15263792.
14. Guo W, Wang N, Li Y, Zhang JH (2005) Polymorphisms in tumor necrosis factor genes and susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high incidence region of North China. Chin Med. J (Engl) 118: 1870-1878
15. Deans C, Rose-Zerilli M, Wigmore S, Ross J, Howell M et al. (2007) Host cytokine genotype is related to adverse prognosis and systemic inflammation in gastro-oesophageal cancer. Ann Surg Oncol 14: 329-339. doi:10.1245/s10434-006- 9122-9. PubMed: 17103073.
16. Corrêa GT, Bandeira GA, Cavalcanti BG, de Carvalho Fraga CA, dos Santos EP et al. (2011) Association of -308 TNF-alpha promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma. Oral Oncol 47: 888-894. doi:10.1016/j.oraloncology.2011.07.001. PubMed: 21788151.
17. Bonizzi G, Karin M (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-288. doi:10.1016/j.it.2004.03.008. PubMed: 15145317.
18. Baldwin AS Jr. (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683. doi:10.1146/annurev. immunol.14.1.649. PubMed: 8717528.
19. Siebenlist U, Franzoso G, Brown K (1994) Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10: 405-455. doi:10.1146/annurev. cellbio.10.1.405. PubMed: 7888182.
20. Whiteside ST, Israël A (1997) I kappa B proteins: structure, function and regulation. Semin Cancer Biol 8: 75-82. doi:10.1006/scbi.1997.0058. PubMed: 9299585.
21. Kang MR, Kim MS, Kim SS, Ahn CH, Yoo NJ et al. (2009) NF-kappaB signalling proteins p50/p105, p52/p100, RelA, and IKKepsilon are over-expressed in oesophageal squamous cell carcinomas. Pathology 41: 622-625. doi:10.3109/00313020903257756. PubMed: 20001340.
22. Tian F, Zang WD, Hou WH, Liu HT, Xue LX (2006) Nuclear factor-kB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA. Acta Biochim Biophys Sin (Shanghai) 38: 318-326. doi:10.1111/j.1745-7270.2006.00166. x. PubMed: 16680372.
23. Yasui K, Imoto I, Fukuda Y, Pimkhaokham A, Yang ZQ et al. (2001) Identification of target genes within an amplicon at 14q12-q13 in esophageal squamous cell carcinoma. Genes Chromosomes Cancer 32: 112-118. doi:10.1002/gcc.1172. PubMed: 11550278.
24. Zou YF, Yuan FL, Feng XL, Tao JH, Ding N et al. (2011) Association between NFKB1 -94ins/delATTG promoter polymorphism and cancer risk: a meta-analysis. Cancer Invest 29: 78-85. doi:10.3109/07357907.2010.535054. PubMed: 21166501.
25. Gao J, Pfeifer D, He LJ, Qiao F, Zhang Z et al. (2007) Association of NFKBIA polymorphism with colorectal cancer risk and prognosis in Swedish and Chinese populations. Scand J Gastroenterol 42: 345-350. doi:10.1080/ 00365520600880856. PubMed: 17354114.
26. Lin CW, Hsieh YS, Hsin CH, Su CW, Lin CH et al. (2012) Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer. PLOS ONE 7: e35078. doi:10.1371/journal.pone.0035078. PubMed: 22509384.
27. Cheng CW, Su JL, Lin CW, Su CW, Shih CH et al. (2013) Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features. PLOS ONE 8: e56130. doi:10.1371/journal.pone. 0056130. PubMed: 23457512.
28. Kim JG, Sohn SK, Chae YS, Moon JH, Kim SN et al. (2009) No association of the NFKB1 insertion/deletion promoter polymorphism with survival in patients with gastric cancer. Jpn J Clin Oncol 39: 497-501. doi:10.1093/jjco/hyp056. PubMed: 19509001.
29. Lehnerdt GF, Bankfalvi A, Grehl S, Adamzik M, Lang S et al. (2008) No association of the NF-kappaB1 -94ins/delATTG promoter polymorphism with relapse-free and overall survival in patients with squamous cell carcinomas of the head and neck region. Int J Immunopathol Pharmacol 21: 827-832. PubMed: 19144268.
30. Jain M, Kumar S, Lal P, Tiwari A, Ghoshal UC et al. (2007) Association of genetic polymorphisms of N-acetyltransferase 2 and susceptibility to esophageal cancer in north Indian population. Cancer Invest 25: 340-346. doi:10.1080/07357900701358074. PubMed: 17661210.
31. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215. doi:10.1093/nar/16.3.1215. PubMed: 3344216.
32. Ye S, Dhillon S, Ke X, Collins AR, Day IN (2001) An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 29: E88-E88. doi:10.1093/nar/29.17.e88. PubMed: 11522844.
33. Zhou B, Rao L, Li Y, Gao L, Wang Y et al. (2009) A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma. Cancer Lett 275: 72-76. doi:10.1016/j.canlet.2008.10.002. PubMed: 19006646.
34. He Y, Zhang H, Yin J, Xie J, Tan X et al. (2009) IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C. Carcinogenesis 30: 1916-1922. doi:10.1093/carcin/bgp226. PubMed: 19797428.
35. Gauderman WJ, Morrison JM (2006) QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. http://hydrauscedu/gxe.
36. Dupont WD, Plummer WD (1997) PS power and sample size program available for free on the internet. Control Clin Trials 18: 274. doi:10.1016/S0197- 2456(97)00074-3.
37. Yoo J, Seo B, Kim Y (2005) SNPAnalyzer: a web-based integrated workbench for single-nucleotide polymorphism analysis. Nucleic Acids Res 33: W483-W488. doi:10.1093/nar/gki428. PubMed: 15980517.
38. Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B (2008) Association of interleukin-6 (-174G>C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: an exploratory study. Clin Immunol 128: 199-204. doi:10.1016/j.clim.2008.03.519. PubMed: 18502691.
39. Tao YP, Wang WL, Li SY, Zhang J, Shi QZ et al. (2012) Associations between polymorphisms in IL-12A, IL-12B, IL-12Rbeta1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer. J Cancer Res Clin Oncol 138: 1891-1900. doi:10.1007/s00432-012-1269-0. PubMed: 22740240.
40. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB et al. (1993) An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 177: 557-560. doi:10.1084/jem.177.2.557. PubMed: 8426126.
41. Abraham LJ, French MA, Dawkins RL (1993) Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol 92: 14-18. PubMed: 8096802.
42. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94: 3195-3199. doi:10.1073/pnas.94.7.3195. PubMed: 9096369.
43. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N et al. (1998) Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 113: 401-406. doi:10.1046/j.1365-2249.1998. 00662.x. PubMed: 9737669.
44. Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ et al. (2004) Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 13: 35-45. PubMed: 14613970.
45. Tang T, Cui S, Deng X, Gong Z, Jiang G et al. (2010) Insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for superficial bladder cancer in Chinese. DNA Cell Biol 29: 9-12. doi:10.1089/dna.2009.0937. PubMed: 19778281.
46. Zhou B, Qie M, Wang Y, Yan L, Zhang Z et al. (2010) Relationship between NFKB1 -94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk. Ann Oncol 21: 506-511. doi:10.1093/annonc/mdp507. PubMed: 19892748.
47. Zhang P, Wei Q, Li X, Wang K, Zeng H et al. (2009) A functional insertion/deletion polymorphism in the promoter region of the NFKB1 gene increases susceptibility for prostate cancer. Cancer Genet Cytogenet 191: 73-77. doi:10.1016/j.cancergencyto.2009.01.017. PubMed: 19446741.
48. Riemann K, Becker L, Struwe H, Rübben H, Eisenhardt A et al. (2007) Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer. Int J Clin Pharmacol Ther 45: 423-430. doi:10.5414/CPP45423. PubMed: 17725175.
49. Riemann K, Becker L, Struwe H, Nückel H, Dührsen U et al. (2006) No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia. Pharmacogenet Genomics 16: 783-788. doi:10.1097/01.fpc.0000230414.74726.f6. PubMed: 17047486.
50. Bouman A, Heineman MJ, Faas MM (2005) Sex hormones and the immune response in humans. Hum Reprod Update 11: 411-423. doi:10.1093/humupd/dmi008. PubMed: 15817524.
51. Jain SK, Kannan K, Prouty L (2004) Progesterone, but not 17beta-estradiol, increases TNF-alpha secretion in U937 monocytes. Cytokine 26: 102-105. doi:10.1016/j.cyto.2004.01.002. PubMed: 15135803.
52. Umar M, Upadhyay R, Kumar S, Ghoshal UC, Mittal B (2011) CASP8 -652 6N del and CASP8 IVS12-19G>A gene polymorphisms and susceptibility/prognosis of ESCC: a case control study in northern Indian population. J Surg Oncol 103: 716-723. doi:10.1002/jso.21881. PubMed: 21308686.
53. Upadhyay R, Khurana R, Kumar S, Ghoshal UC, Mittal B (2011) Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophageal cancer in northern India. Ann Surg Oncol 18: 880-887. doi:10.1245/s10434-010-1371-y. PubMed: 20957442.
54. Kim WW, Hong KH, Jang WH, Kim HI, Seo JY et al. (2005) Tumor Necrosis Factor-alpha-308G/A Promoter Polymorphism is Associated with the Severity of Gastric Carcinomas. J Korean Surg Soc 68: 288-295.
55. Song S, Chen D, Lu J, Liao J, Luo Y et al. (2011) NFkappaB1 and NFkappaBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population. PLOS ONE 6: e21726. doi:10.1371/journal.pone.0021726. PubMed: 21738780.
56. Bu H, Rosdahl I, Sun XF, Zhang H (2007) Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients. J Cancer Res Clin Oncol 133: 859-866. doi:10.1007/s00432-007-0228-7. PubMed: 17492467.